Table 2.
Human Papillomavirus Vaccination and Infection Stratified by Race/Ethnicity and Confirmed HIV Status
| Total | Race/ethnicity | Confirmed HIV status | |||||
|---|---|---|---|---|---|---|---|
| Latino | White | Black | Other | HIV+ | HIV− | ||
| % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | % (n) | |
| Vaccination status | |||||||
| Fully vaccinated | 18.1 (88) | 19.2 (30) | 20.7 (25) | 16.5 (20) | 16.9 (13) | 27.3 (9) | 17.9 (79) |
| Partially vaccinated | 24.3 (118) | 30.1 (47) | 17.4 (21) | 26.4 (32) | 23.4 (18) | 33.1 (11) | 24.2 (107) |
| Not vaccinated | 45.1 (219) | 40.4 (63) | 53.7 (65) | 47.1 (57) | 44.2 (34) | 33.3 (11) | 47.1 (208) |
| Unsure | 10.3 (50) | 10.3 (16) | 8.3 (10) | 9.9 (12) | 15.6 (12) | 6.1 (2) | 10.9 (48) |
| Anal HPV | |||||||
| High risk | 34.6 (162) | 34.2 (54) | 33.6 (39) | 35.0 (41) | 36.4 (28) | 43.8 (14) | 33.9 (148) |
| Low risk† | 30.1 (141) | 25.9 (41) | 27.6 (32) | 34.2 (40) | 36.4 (28) | 56.3 (18) | 28.2 (123) |
| Unknown risk* | 7.3 (34) | 5.1 (8) | 12.9 (15) | 3.4 (4) | 9.1 (7) | 3.1 (1) | 7.6 (33) |
| Any anal | 58.1 (272) | 56.3 (89) | 58.6 (68) | 55.6 (65) | 64.9 (50) | 78.1 (25) | 56.7 (247) |
| Oral HPV | |||||||
| High risk*,† | 4.7 (23) | 1.9 (3) | 5.7 (7) | 4.0 (5) | 10.1 (8) | 12.1 (4) | 4.2 (19) |
| Low risk† | 3.1 (15) | 1.9 (3) | 2.5 (3) | 4.8 (6) | 3.8 (3) | 9.1 (3) | 2.6 (12) |
| Unknown risk | 1.0 (5) | 1.2 (2) | 0.0 (0) | 2.4 (3) | 0.0 (0) | 3.0 (1) | 0.9 (4) |
| Any oral† | 8.8 (43) | 5.0 (8) | 8.2 (10) | 11.3 (14) | 13.9 (11) | 24.2 (8) | 7.7 (35) |
| Vaccine-preventable HPV† | 32.1 (150) | 31.0 (49) | 28.4 (33) | 33.3 (39) | 37.7 (29) | 53.1 (17) | 30.5 (133) |
| Any HPV† | 60.6 (285) | 58.2 (92) | 60.3 (70) | 58.5 (69) | 69.2 (54) | 87.9 (29) | 58.6 (256) |
*
Significant differences by race/ethnicity, p < 0.05.
†
Significant differences by HIV status, p < 0.05.
HPV, human papillomavirus.